Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

被引:9
作者
Kyritsi, Eleni-Magdalini [1 ]
Koltsida, Georgia [1 ]
Farakla, Ioanna [1 ]
Papanikolaou, Aikaterini [2 ]
Critselis, Elena [1 ]
Mantzou, Emilia [1 ]
Zoumakis, Emmanouil [1 ]
Kolaitis, Gerasimos [2 ]
Chrousos, George P. [1 ,3 ]
Charmandari, Evangelia [1 ,3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet,Dept Pediat 1, Thivon & Papadiamantopoulou St, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Dept Child Psychiat, Athens, Greece
[3] Acad Athens, Div Endocrinol & Metab, Biomed Res Fdn, Clin Res Ctr, Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2017年 / 16卷 / 01期
关键词
Anxiety; Carriers; Congenital adrenal hyperplasia; Depression; 21-hydroxylase deficiency; HORMONE-RECEPTOR ANTAGONIST; HPA AXIS; SALIVARY CORTISOL; DEPRESSION; ANXIETY; SYSTEM; DISORDERS; CRH; NEUROENDOCRINE; INVENTORY;
D O I
10.14310/horm.2002.1718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Carriers of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) demonstrate increased secretion of cortisol precursors following ACTH stimulation, suggestive of impaired cortisol production and compensatory increases in hypothalamic corticotropin-releasing hormone (CRH) secretion. Both cortisol and CRH have behavioral effects, and hypothalamic CRH hypersecretion has been associated with chronic states of anxiety and depression. We performed an endocrinologic and psychological evaluation in carriers of 21-OHD and matched control subjects. DESIGN: We recruited 29 parents of children with classic CAH (14 males, 15 females; age (mean +/- SD): 41.8 +/- 5.7 yr), and hence 21-OHD carriers, and 13 normal subjects (5 males, 8 females; age: 43.8 +/- 6.1 yr). All subjects underwent a formal ovine (o) CRH stimulation test with measurement of ACTH, cortisol, 17-hydroxyprogesterone (17-OHP) and androstenedione concentrations, which was preceded by determination of 24-hour urinary free cortisol (UFC) excretion. Psychometric assessment was performed by administering the State-Anxiety (STAI 1) and Trait-Anxiety (STAI 2) Inventory, Beck Depression Inventory, Symptom Checklist-90R and Temperament and Character Inventory. RESULTS : Carriers of 21-OHD had significantly higher 17-OHP concentrations following oCRH stimulation and higher STAI 1 (47.6 +/- 5.6 vs. 43.3 +/- 5.4, P=0.023) scores than control subjects. Mean 24-hour UFC concentrations were positively correlated with paranoid ideation (r=0.435; P=0.023) and psychoticism (r=0.454; P=0.017). Stepwise multiple linear regression analysis revealed that the single independent predictor of STAI 1 was peak stimulated 17-OHP concentrations (beta: 0.055, SE: 0.023, R-2: 0.290, P=0.031). CONCLUSIONS : Carriers of 21-OHD may be predisposed to the development of anxiety disorders.
引用
收藏
页码:42 / 53
页数:12
相关论文
共 50 条
[21]   Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
冯韵霖 ;
朱慧娟 ;
龚凤英 ;
李乃适 ;
潘慧 ;
陆召麟 ;
史轶蘩 .
生殖医学杂志, 2007, (S1) :16-19
[22]   Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
Tania Mayvel Espinosa Reyes ;
Teresa Collazo Mesa ;
Paulina Arasely Lantigua Cruz ;
Adriana Agramonte Machado ;
Emma Domínguez Alonso ;
Henrik Falhammar .
BMC Endocrine Disorders, 20
[23]   Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
Rohrer, TR ;
Gassmann, KF ;
Pavel, ME ;
Dörr, HG .
BIOLOGY OF THE NEONATE, 2003, 83 (01) :65-68
[24]   Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults [J].
Bachelot, Anne ;
Chakthoura, Zeina ;
Rouxel, Agnes ;
Dulon, Jerome ;
Touraine, Philippe .
HORMONE RESEARCH, 2008, 69 (04) :203-211
[25]   Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
Espinosa Reyes, Tania Mayvel ;
Collazo Mesa, Teresa ;
Lantigua Cruz, Paulina Arasely ;
Agramonte Machado, Adriana ;
Dominguez Alonso, Emma ;
Falhammar, Henrik .
BMC ENDOCRINE DISORDERS, 2020, 20 (01)
[26]   Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J].
Doerr, Helmuth G. .
HORMONE RESEARCH, 2007, 68 :93-99
[27]   Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns [J].
Abali, Zehra Yavas ;
Kurnaz, Erdal ;
Guran, Tulay .
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2025, 17 :33-43
[28]   Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Genotype-phenotype correlation [J].
Fontes, Natacha ;
Pereira, Marco ;
Nascimento, Marta ;
Oliveira, Eliana ;
Espada, Filipa V. ;
Fonseca, Marcelo .
REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2012, 7 (02) :8-12
[29]   Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: The Italian experience [J].
Brunelli, VL ;
Russo, G ;
Bertelloni, S ;
Gargantini, L ;
Balducci, R ;
Chiesa, L ;
Livieri, C ;
De Sanctis, C ;
Einaudi, S ;
Virdis, R ;
Saggese, G ;
Chiumello, G .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 :277-283
[30]   Clinical, Biochemical and Molecular Characteristics of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency [J].
Gunes, Sevinc Odabasi ;
Kendirci, Havva Nur Peltek ;
Unal, Edip ;
Bulus, Ayse Derya ;
Dundar, Ismail ;
Siklar, Zeynep .
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2025, 17 :3-11